Enasidenib drives human erythroid differentiation independently of isocitrate dehydrogenase 2.
Dutta R, Zhang TY, Köhnke T, Thomas D, Linde M, Gars E, Stafford M, Kaur S, Nakauchi Y, Yin R, Azizi A, Narla A, Majeti R.
Dutta R, et al. Among authors: zhang ty.
J Clin Invest. 2020 Apr 1;130(4):1843-1849. doi: 10.1172/JCI133344.
J Clin Invest. 2020.
PMID: 31895700
Free PMC article.